Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

TxSCO Update August 2024 Copyright© 2024 ADVI Health. All Rights Reserved.Copyright© 2024 ADVI Health. All Rights Reserved.1 TxSCO Update August 8, 2024 ADVI & HillCo Copyright© 2024 ADVI Health. All Rights Reserved.2 Federal Updates Copyright© 2024 ADVI Health. All Rights Reserved.3 2024 Election: Polls in Flux, Though Latest Predictions Favor Republicans …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TxSCO ONCOLOGY DRUG NEWSLETTER A U G U S T 2 0 2 4 FDA APPROVALS Tepylute (SH-105) The FDA has approved Tepylute (SH-105), a ready- to-dilute formulation of an existing treatment for breast and ovarian adenocarcinoma.1 The original …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. SCOS ONCOLOGY DRUG NEWSLETTER A U G U S T 2 0 2 4 FDA APPROVALS Tepylute (SH-105) The FDA has approved Tepylute (SH-105), a ready- to-dilute formulation of an existing treatment for breast and ovarian adenocarcinoma.1 The original …
Published in Oncology News Central Aug 6, 2024 The Association of Cancer Care Centers (ACCC), formerly the Association of Community Cancer Centers, has hired Meagan O. O’Neill, MS, as its new executive director. O’Neill, who started in the role on July 15, is only the third executive director in the organization’s history and is the first woman to serve in the position. She replaces Christian G. …
August 9, 2024
Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options The Community Oncology Connections™ Program will feature didactic presentations coupled with cases and discussion. This provides an ideal format to exchange ideas and viewpoints, as well as to hear experts apply the latest practice-changing clinical trial data, evidence-based testing, and therapeutic strategies …
In this episode, CANCER BUZZ speaks with Karen Fancher, PharmD, BCOP, clinical pharmacy specialist in oncology at University of Pittsburgh – Passavant Hospital, and Victoria Nachar, PharmD, BCOP, clinical pharmacist specialist in ambulatory hematology and adjunct clinical instructor at the University of Michigan, about strategies to address common adverse events experienced by patients with mantle …
August 8, 2024
Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals This meeting series is designed to bring community oncology practitioners up to speed on the current and emerging best practices for the management of MDS, taking into account recent drug approvals and new …
1 Prior Authorization Prior authorization (PA) requirements have become a top concern of cancer care providers and their patients. These utilization management mechanisms aim to curb the provision of care that is not medically necessary or appropriate. Yet in practice they may hinder patients’ access to necessary services and treatments, potentially leading to delays in care and harm …
IOS-IN 2024 Oncology Practice Summit Friday August 16, 2024 Embassy Suites Noblesville Indianapolis Conference Center Noblesville, IN Attendee Roster First Name Last Name Title Account Name Kim Chambers Patient Navigator American Oncology Network Jennifer Bell Account Specialist Amgen Nicole Constantino Executive Sales Representative Amgen Christy Jennings Sales Representative …
Developed in Partnership with: Actively Participating in Your Care You and Your Doctor: A Toolkit For Those Living With Or Caring For Someone With Diffuse Large B-Cell Lymphoma (DLBCL) 2 | You and Your Doctor: Actively Participating In Your Care Welcome! The purpose of this Toolkit is to help support your experience as someone living with Diffuse Large B-Cell …
August 8, 2024
PACIFICO Yokohama North Yokohama, Japan (Online Option Available Too) ASCO® is thrilled to connect practicing clinicians, oncology thought leaders, medtech pioneers, and research trailblazers to spark new conversations and partnerships that transcend disciplines and nations. The meeting is endorsed by the Japan Ministry of Health, Labor and Welfare. Learn more and register today!
August 6, 2024
Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals This meeting series is designed to bring community oncology practitioners up to speed on the current and emerging best practices for the management of MDS, taking into account recent drug approvals and new …
August 6, 2024
As of January 1, 2024, the Centers for Medicare and Medicaid Services introduced new codes so that Medicare could reimburse for patient navigation services, addressing a long-standing need. In order to guide implementation the Association of Cancer Care Centers will be holding a 4-part webinar series, Implementing the New CMS Reimbursement Billing Codes for Patient Navigation Services. This webinar …
August 3, 2024
Sheraton Overland Park Hotel at the Convention Center 6100 College Boulevard Overland Park, KS 66211 Total Health's 2024 ASCO Direct™ Kansas City Conference is an officially licensed ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will …
OUR MISSION: MONTANA STATE ONCOLOGY SOCIETY 1801 Research Boulevard, Suite 400, Rockville, Maryland 20850 Phone: 301.984.9496 www.msos-montana.com Oncology State Societies at ACCC Engage & Succeed. APPLICATION FOR MEMBERSHIP Complete this application for annual membership (January 1–December 31) and email it to the Membership Department at …
Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education Working Summit Highlights ASSOCIATION OF CANCER CARE CENTERS Where We Are As of 2024, 6 chimeric antigen receptor (CAR) T-cell therapies have been approved by the Food and Drug Administration (FDA) to treat hematologic malignancies. However, a substantial percentage of patients eligible for CAR T-cell therapy …
OUR MISSION: WYOMING STATE ONCOLOGY SOCIETY 1801 Research Boulevard, Suite 400, Rockville, Maryland 20850 Phone: 301.984.9496 www.wsos-wyoming.com Oncology State Societies at ACCC Engage & Succeed. APPLICATION FOR MEMBERSHIP Complete this application for annual membership (January 1–December 31) and email it to the Membership Department at …
ASSOCIATION OF CANCER CARE CENTERS ADVANCING CAR T-CELL THERAPY CARE CONTINUITY AND COLLABORATIVE PATIENT EDUCATION Summary of a Working Summit Developing a Health Literacy and Clear Communications e-Course INTRODUCTION Chimeric antigen receptor (CAR) T-cell therapies offer the promise of increased disease-free survival to patients with relapsed/refractory …